Jubilant Pharmova Limited JUBLPHARMA.NS Stock
Jubilant Pharmova Limited Price Chart
Jubilant Pharmova Limited JUBLPHARMA.NS Financial and Trading Overview
| Jubilant Pharmova Limited stock price | 638 INR |
| Previous Close | 386.8 INR |
| Open | 389 INR |
| Bid | 401.55 INR x N/A |
| Ask | 402.1 INR x N/A |
| Day's Range | 387.05 - 403 INR |
| 52 Week Range | 268.9 - 423.9 INR |
| Volume | 301.17K INR |
| Avg. Volume | 276.67K INR |
| Market Cap | 64B INR |
| Beta (5Y Monthly) | 1.636986 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 2.36 INR |
| Forward Dividend & Yield | 5 (1.35%) |
| Ex-Dividend Date | August 11, 2022 |
| 1y Target Est | N/A |
JUBLPHARMA.NS Valuation Measures
| Enterprise Value | 86.04B INR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.0188133 |
| Price/Book (mrq) | 1.1839027 |
| Enterprise Value/Revenue | 1.37 |
| Enterprise Value/EBITDA | 11.084 |
Trading Information
Jubilant Pharmova Limited Stock Price History
| Beta (5Y Monthly) | 1.636986 |
| 52-Week Change | 16.13% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 423.9 INR |
| 52 Week Low | 268.9 INR |
| 50-Day Moving Average | 329.67 INR |
| 200-Day Moving Average | 340.67 INR |
JUBLPHARMA.NS Share Statistics
| Avg. Volume (3 month) | 276.67K INR |
| Avg. Daily Volume (10-Days) | 206.13K INR |
| Shares Outstanding | 159.28M |
| Float | 53.31M |
| Short Ratio | N/A |
| % Held by Insiders | 58.88% |
| % Held by Institutions | 17.38% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 5 |
| Trailing Annual Dividend Yield | 1.29% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 21:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | -0.97% |
| Operating Margin (ttm) | 3.53% |
| Gross Margin | 70.10% |
| EBITDA Margin | 12.35% |
Management Effectiveness
| Return on Assets (ttm) | 1.31% |
| Return on Equity (ttm) | -1.21% |
Income Statement
| Revenue (ttm) | 62.82B INR |
| Revenue Per Share (ttm) | 394.54 INR |
| Quarterly Revenue Growth (yoy) | 9.90% |
| Gross Profit (ttm) | 44.42B INR |
| EBITDA | 7.76B INR |
| Net Income Avi to Common (ttm) | -609800000 INR |
| Diluted EPS (ttm) | -3.83 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.14B INR |
| Total Cash Per Share (mrq) | 63.76 INR |
| Total Debt (mrq) | 36.77B INR |
| Total Debt/Equity (mrq) | 68.19 INR |
| Current Ratio (mrq) | 2.123 |
| Book Value Per Share (mrq) | 339.386 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 6.61B INR |
| Levered Free Cash Flow (ttm) | -1203415040 INR |
Profile of Jubilant Pharmova Limited
| Country | India |
| State | N/A |
| City | Noida |
| Address | 1A, Sector 16A |
| ZIP | 201301 |
| Phone | 91 12 0436 1000 |
| Website | https://www.jubilantpharmova.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Jubilant Pharmova Limited operates as an integrated pharmaceutical and life sciences company worldwide. It operates through three segments: Pharmaceuticals; Contract Research & Development Services; and Proprietary Novel Drugs. The Pharmaceuticals segment engages in the manufacturing and supply of allergy therapy products, contract manufacturing of sterile injectables and non-sterile products, active pharmaceutical ingredients, and solid dosage formulations, as well as sale of radiopharmaceuticals through a network of 48 radio pharmacies in the United States. The Contract Research & Development Services segment provides collaborative research services to pharmaceutical innovators. The Proprietary Novel Drugs segment develops therapies in the areas of oncology and auto-immune disorders. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. Jubilant Pharmova Limited was incorporated in 1978 and is based in Noida, India.
Q&A For Jubilant Pharmova Limited Stock
What is a current JUBLPHARMA.NS stock price?
Jubilant Pharmova Limited JUBLPHARMA.NS stock price today per share is 638 INR.
How to purchase Jubilant Pharmova Limited stock?
You can buy JUBLPHARMA.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Jubilant Pharmova Limited?
The stock symbol or ticker of Jubilant Pharmova Limited is JUBLPHARMA.NS.
Which industry does the Jubilant Pharmova Limited company belong to?
The Jubilant Pharmova Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Jubilant Pharmova Limited have in circulation?
The max supply of Jubilant Pharmova Limited shares is 158.71M.
What is Jubilant Pharmova Limited Price to Earnings Ratio (PE Ratio)?
Jubilant Pharmova Limited PE Ratio is 270.33900000 now.
What was Jubilant Pharmova Limited earnings per share over the trailing 12 months (TTM)?
Jubilant Pharmova Limited EPS is 2.36 INR over the trailing 12 months.
Which sector does the Jubilant Pharmova Limited company belong to?
The Jubilant Pharmova Limited sector is Healthcare.